Interestingly, CDK4 expression was not elevated in lenvatinib-resistant HCC cells and lenvatinib-resistant HCC xenograft tumor compared to the corresponding mock controls (Fig. 1h, Supplementary Fig. 2). Here, CDK4 is linked to hepatocellular carcinoma.